purpos
receiv
influenza
vaccin
may
increas
risk
respiratori
virus
phenomenon
known
viru
interfer
testneg
studi
design
often
util
calcul
influenza
vaccin
effect
viru
interfer
phenomenon
goe
basic
assumpt
testneg
vaccin
effect
studi
vaccin
chang
risk
infect
respiratori
ill
thu
potenti
bias
vaccin
effect
result
posit
direct
studi
aim
investig
viru
interfer
compar
respiratori
viru
statu
among
depart
defens
personnel
base
influenza
vaccin
statu
furthermor
individu
respiratori
virus
associ
influenza
vaccin
examin
result
compar
vaccin
statu
peopl
noninfluenza
respiratori
virus
peopl
panneg
result
compar
vaccin
nonvaccin
patient
adjust
odd
ratio
nonflu
virus
confid
interv
ci
p
addit
vaccin
statu
case
influenza
compar
three
differ
control
group
control
n
noninfluenza
posit
control
n
panneg
control
n
adjust
or
comparison
among
three
control
group
vari
much
rang
conclus
receipt
influenza
vaccin
associ
viru
interfer
among
popul
examin
viru
interfer
specif
respiratori
virus
show
mix
result
vaccin
deriv
viru
interfer
significantli
associ
coronaviru
human
metapneumoviru
howev
signific
protect
vaccin
associ
influenza
virus
also
parainfluenza
rsv
noninfluenza
viru
coinfect
publish
elsevi
ltd
influenza
pandem
contribut
estim
million
death
worldwid
stimul
interest
influenza
vaccin
research
twenti
year
pandem
began
first
influenza
vaccin
administ
us
soldier
influenza
season
season
exclud
season
influenza
vaccin
shown
effect
reduc
burden
season
influenza
unit
state
influenza
vaccin
offer
protect
influenza
natur
influenza
infect
may
reduc
risk
noninfluenza
respiratori
virus
provid
temporari
nonspecif
immun
virus
hand
recent
publish
studi
describ
phenomenon
vaccineassoci
viru
interfer
vaccin
individu
may
increas
risk
respiratori
virus
receiv
nonspecif
immun
associ
natur
infect
limit
evid
influenza
vaccin
may
actual
associ
viru
interfer
process
studi
found
associ
influenza
vaccin
increas
respiratori
viru
risk
purpos
studi
add
gener
knowledg
influenza
vaccinerel
viru
interfer
compar
rate
http
studi
aim
examin
relationship
specif
respiratori
virus
influenza
vaccin
protocol
studi
review
approv
exempt
air
forc
research
laboratori
institut
review
board
depart
defens
global
respiratori
pathogen
surveil
program
dodgr
dodwid
program
establish
global
emerg
infect
surveil
respons
system
gei
program
found
influenzaonli
surveil
program
influenza
season
program
ad
respiratori
film
array
flu
neg
sampl
began
identifi
respiratori
pathogen
start
influenza
season
program
ad
luminex
film
array
capabl
test
respiratori
pathogen
becam
known
dodgr
defens
health
agencyarm
forc
health
surveil
branch
air
forc
satellit
cell
dha
afhsb
af
unit
state
air
forc
school
aerospac
medicin
usafsam
manag
surveil
program
includ
global
surveil
among
dod
beneficiari
sentinel
site
includ
deploy
locat
mani
nonsentinel
site
laboratori
test
complet
usafsam
landstuhl
region
medic
center
lrmc
includ
multiplex
pcr
respiratori
pathogen
panel
includ
adenoviru
chlmydia
pneumonia
coronaviru
human
bocaviru
human
metapnumoviru
mycoplasma
pneumonia
parainfluenza
respiratori
syncyti
viru
rsv
rhinovirusenteroviru
coinfect
viral
cultur
detect
influenza
respiratori
virus
influenza
ab
subtyp
via
pcr
vaccin
statu
deriv
air
forc
complet
immun
track
applic
afcita
unit
state
air
forc
databas
contain
vaccinationrel
data
survey
given
submit
respiratori
sampl
patient
influenza
vaccin
record
afcita
influenza
season
answer
ye
vaccin
season
survey
identifi
vaccin
patient
vaccin
season
vaccin
less
day
prior
specimen
submitt
classifi
unvaccin
peopl
submit
respiratori
specimen
dodgr
influenza
season
elig
studi
influenza
season
began
octob
end
septemb
submit
sampl
test
posit
chlamydia
pneumonia
andor
mycoplasma
pneumonia
exclud
ill
bacteriolog
natur
viral
peopl
influenza
noninfluenza
coinfect
exclud
could
uniqu
classifi
either
influenza
noninfluenza
respiratori
viru
individu
multipl
specimen
collect
season
also
remov
studi
could
multipl
differ
virus
season
specimen
neither
vaccin
statu
could
obtain
via
databas
questionnair
complet
exclud
vaccin
statu
could
confirm
subject
ill
receiv
vaccin
exclud
vaccin
statu
would
therefor
unrel
ill
lastli
peopl
laboratori
reject
specimen
includ
final
studi
popul
data
manag
statist
analys
conduct
use
sa
sa
enterpris
guid
sa
institut
inc
cari
nc
basic
descript
epidemiolog
util
obtain
count
rate
outcom
sex
militari
beneficiari
categori
age
group
diseas
statu
season
ill
vaccin
statu
order
determin
viru
interfer
associ
influenza
vaccin
militari
beneficiari
popul
odd
ratio
confid
interv
calcul
util
condit
logist
regress
compar
vaccin
statu
two
analys
first
viral
respiratori
ill
influenza
compar
pathogen
detect
panneg
next
influenza
posit
case
compar
three
differ
control
group
first
control
group
compris
control
specif
individu
test
neg
flu
posit
respiratori
viru
flu
second
control
group
consist
posit
respiratori
virus
influenza
lastli
panneg
control
compar
influenza
case
unadjust
adjust
odd
ratio
calcul
overal
popul
popul
afcita
record
activ
duti
popul
influenza
season
comparison
respiratori
ill
panneg
well
three
casecontrol
comparison
adjust
odd
ratio
calcul
model
variabl
nest
logist
regress
keep
variabl
p
ad
full
logist
model
full
logist
model
variabl
remain
signific
includ
final
adjust
model
age
group
remain
signific
overal
popul
age
group
season
remain
signific
afcita
confirm
vaccin
group
activ
duti
popul
gender
age
group
season
remain
signific
three
casecontrol
comparison
respect
variabl
remain
signific
includ
adjust
odd
ratio
total
season
individu
respiratori
viru
outcom
also
examin
stratifi
vaccin
statu
odd
ratio
confid
interv
pvalu
calcul
determin
individu
respiratori
virus
associ
influenza
vaccin
influenza
season
specimen
test
posit
influenza
data
shown
specimen
identifi
respiratori
pathogen
remain
specimen
result
neg
data
shown
specimen
specimen
exclud
popul
base
exclusionari
criteria
describ
method
section
leav
final
studi
popul
uniqu
peopl
data
shown
studi
popul
predominantli
male
activ
duti
servic
member
age
year
old
tabl
major
studi
popul
vaccin
tabl
respiratori
specimen
analyz
winter
decemb
januari
februari
month
tabl
test
posit
respiratori
viru
influenza
similar
breakdown
sex
vaccin
statu
season
ill
compar
panneg
tabl
respiratori
posit
group
child
beneficiari
overal
younger
panneg
group
tabl
examin
demograph
characterist
stratifi
vaccin
statu
male
like
vaccin
femal
tabl
activ
duti
member
like
vaccin
peopl
beneficiari
status
tabl
younger
age
popul
like
unvaccin
compar
age
group
tabl
composit
lab
result
respiratori
viru
influenza
pathogen
detect
distribut
fairli
evenli
among
vaccin
popul
howev
unvaccin
peopl
like
specimen
result
influenza
tabl
winter
predomin
season
ill
specimen
test
tabl
among
studi
popul
peopl
afcita
vaccin
record
peopl
selfreport
vaccin
statu
via
questionnair
data
shown
examin
popul
respiratori
virus
viru
detect
vaccin
lower
unadjust
odd
ci
respiratori
virus
compar
unvaccin
tabl
adjust
age
group
odd
lower
ci
respiratori
virus
vaccin
popul
tabl
unadjust
data
shown
statist
signific
howev
adjust
odd
remain
statist
signific
p
tabl
sinc
selfreport
vaccin
statu
may
accur
may
bia
result
afcita
confirm
vaccin
examin
exclus
vaccin
accord
afcita
record
lower
unadjust
odd
ci
respiratori
virus
compar
unvaccin
tabl
adjust
age
group
season
increas
odd
higher
ci
respiratori
virus
vaccin
popul
tabl
neither
unadjust
odd
data
shown
adjust
odd
p
afcita
popul
signific
viru
interfer
also
examin
among
activ
duti
season
vaccin
slightli
lower
unadjust
odd
ci
respiratori
virus
compar
unvaccin
tabl
adjust
age
season
odd
increas
higher
odd
ci
respiratori
virus
vaccin
popul
howev
unadjust
data
shown
adjust
p
odd
ratio
statist
signific
tabl
unadjust
adjust
odd
influenza
significantli
lower
vaccin
popul
three
control
group
tabl
adjust
or
rang
panneg
comparison
noninfluenza
viru
posit
comparison
tabl
ci
adjust
or
three
comparison
group
overlap
differ
detect
among
control
group
compar
influenza
case
odd
test
posit
individu
respiratori
virus
vaccin
statu
also
examin
tabl
influenza
vaccin
suffici
protect
influenza
viru
result
test
signific
level
except
two
influenza
b
victoria
influenza
coinfect
tabl
influenza
b
victoria
influenza
coinfect
reduc
odd
vaccin
cohort
signific
level
tabl
examin
noninfluenza
virus
specif
odd
coronaviru
human
metapneumoviru
vaccin
individu
significantli
higher
compar
unvaccin
individu
respect
tabl
convers
noninfluenza
respiratori
virus
decreas
odd
vaccin
popul
includ
significantli
decreas
odd
ratio
vaccin
peopl
parainfluenza
rsv
noninfluenza
viru
coinfect
tabl
addit
odd
ratio
pathogen
detect
cohort
significantli
higher
vaccin
versu
unvaccin
individu
tabl
examin
peopl
respiratori
virus
influenza
panneg
result
submit
respiratori
specimen
laboratori
test
dodgr
team
receiv
influenza
vaccin
decreas
risk
respiratori
pathogen
identifi
compar
unvaccin
group
one
studi
unit
state
found
similar
result
studi
found
influenza
vaccin
associ
detect
noninfluenza
respiratori
virus
addit
laboratori
data
studi
show
increas
odd
coronaviru
human
metapneumoviru
individu
receiv
influenza
vaccin
studi
find
similar
result
studi
found
associ
influenza
vaccin
rsv
adenoviru
human
metapneumoviru
rhinoviru
coronaviru
studi
find
signific
associ
parainfluenza
influenza
vaccin
associ
opposit
direct
compar
children
adult
diseas
specif
investig
viru
interfer
trend
notic
coronaviru
human
metapneumoviru
howev
two
specif
respiratori
virus
parainfluenza
rsv
show
signific
protect
associ
influenza
vaccin
receipt
other
test
adenoviru
human
bocaviru
rhinovirusenteroviru
show
protect
although
nonsignific
associ
vaccin
tabl
addit
examin
viru
interfer
accomplish
assess
affect
three
noninfluenza
control
group
vaccin
effect
n
adjust
or
three
group
rang
similar
confid
interv
account
differ
vaccin
effect
minut
differ
among
vaccin
effect
three
control
group
support
viru
interfer
concept
testneg
studi
design
often
util
calcul
influenza
vaccin
effect
type
studi
recruit
subject
influenzalik
ill
collect
respiratori
specimen
perform
diagnost
laboratori
test
determin
pathogen
obtain
individu
vaccin
statu
vaccineassoci
viru
interfer
phenomenon
goe
basic
assumpt
testneg
vaccin
effect
studi
vaccin
chang
risk
infect
respiratori
ill
result
studi
support
potenti
bia
testneg
influenza
vaccin
effect
studi
testneg
studi
design
patient
must
sick
influenzalik
ill
sinc
popul
must
ill
vaccin
popul
like
respiratori
virus
compar
nonvaccin
popul
turn
less
like
influenza
bia
introduc
studi
may
caus
overestim
vaccin
effect
mandatori
influenza
vaccin
requir
activ
duti
personnel
vaccin
effect
studi
examin
strictli
activ
duti
militari
member
previous
shown
methodolog
invalid
often
time
uninterpret
result
order
examin
potenti
issu
mandatori
vaccin
beneficiari
categori
includ
logist
regress
model
beneficiari
categori
remain
signific
therefor
kept
final
logist
model
activ
duti
member
separ
rest
popul
viru
interfer
among
popul
calcul
unadjust
adjust
model
show
signific
evid
viru
interfer
activ
duti
member
therefor
larg
portion
popul
appear
skew
studi
result
convers
aforement
vaccin
effect
studi
studi
limit
includ
assumpt
causal
relationship
influenza
vaccin
respiratori
virus
perhap
factor
influenc
rate
respiratori
ill
adjust
condit
logist
regress
analysi
attempt
account
factor
could
influenc
respiratori
outcom
addit
studi
reli
selfreport
vaccin
statu
data
unavail
afcita
miss
vaccin
statu
especi
high
nonact
duti
member
studi
mani
patient
seen
clinic
base
therefor
necessarili
track
afcita
howev
selfreport
vaccin
data
includ
augment
vaccin
statu
afcita
data
unavail
selfreport
data
assum
rel
accur
ensur
selfreport
data
skew
find
afcita
record
examin
exclus
viru
interfer
unadjust
adjust
model
show
signific
evid
viru
interfer
afcita
vaccin
personnel
therefor
vaccin
record
statu
appear
skew
studi
result
viru
interfer
associ
influenza
vaccin
previous
investig
howev
studi
first
viru
interfer
studi
conduct
among
highli
vaccin
dod
personnel
studi
includ
divers
well
dispers
popul
base
sex
age
group
beneficiari
categori
vaccin
statu
addit
popul
size
rel
larg
numer
respiratori
pathogen
examin
previous
individu
investig
viru
interfer
overal
result
studi
show
littl
evid
support
associ
viru
interfer
influenza
vaccin
individu
respiratori
viru
result
mix
rebut
viru
interfer
addit
receiv
influenza
vaccin
like
pathogen
detect
reduc
risk
influenza
compar
unvaccin
individu
research
necessari
help
charact
viru
interfer
valid
refut
valid
testneg
design
influenza
vaccin
effect
view
express
articl
author
necessarili
repres
offici
polici
posit
depart
defens
us
govern
